The power of spike-in controls in RNA-Seq
18. March 2026
RNA sequencing (RNA-Seq) is a powerful technique to assess an organism’s whole transcriptome at unprecedented levels of sensitivity and generate
News & Blog
Read More ›
Building one of the World’s Largest Human Liver Functional Genomics Dataset to Date: Inside the Ochre Bio and Lexogen Partnership
15. December 2025
Building a comprehensive, high-resolution dataset reflecting human liver biology requires more than selecting the right technology, it demands a partner
Lexogen Successfully Completes Large-Scale Human Primary Cell Next Gen Sequencing Project with Ochre Bio
25. November 2025
Vienna, Austria – 25.11.2025 Lexogen, a Vienna-based biotech company specialized in RNA transcriptomics technologies and services announces the completion of a large-scale
Lexogen honored as one of Austria’s Top Innovative Companies 2026 by Statista and trend. magazine
11. November 2025
11.11.2025, Vienna, Austria – Lexogen, a recognized expert in the domain of RNA sequencing and transcriptome analysis, has been recognized among
Lexogen Launches miRVEL Profiling Small RNA-Seq Kit for Streamlined and Cost-Efficient sRNA Expression Analysis
16. October 2025
16.10.2025, Vienna, Austria — Lexogen, a leader in RNA sequencing technologies, announces the launch of the miRVEL Profiling Small RNA-Seq
Choosing Between Whole Transcriptome Total RNA-Seq and 3′ mRNA-Seq: A Practical Guide and Comparison
25. September 2025
Every successful RNA-Seq experiment starts with a thorough and meticulous experimental plan. Designing the experiment is key and one of
Webinar: Beyond the Reads: Designing Successful RNA-Seq Experiments and Data Analyses
27. August 2025
Watch the recording What You Will Learn: Join us for an exciting session on best practices and practical tips for
Precision Cancer Vaccines – How RNA- and DNA-Seq shape the future of neoantigen discovery
8. August 2025
Cancer immunotherapy has transformed the landscape of oncology, offering powerful tools that train the body’s own immune system to fight
How RNA Sequencing is Revolutionizing Cancer Research: Bringing Precision Medicine to Cancer Patients
1. July 2025
RNA sequencing (RNA-Seq) has become an indispensable tool for cancer researchers. Unlike traditional methods, RNA-Seq provides a dynamic snapshot of
Webinar: Bringing Precision Medicine to Cancer Immunotherapy with a Robust RNA Diagnostic Platform
25. June 2025
Watch the recording Learn more about QuantSeq 3’ mRNA-Seq Library Prep Kits. What You Will Learn: Discover how RNA-based
Lexogen Launches miRVEL Discovery – Cutting-edge Small RNA-Seq Library Prep Kit for sRNA Discovery and Biomarker studies
21. May 2025
21.05.2025, Vienna, Austria — Lexogen, a leader in RNA sequencing technologies, is excited to announce the launch of the miRVEL
Planning for Success: A Strategic Design Guide for RNA-Seq Experiments in Drug Discovery
9. April 2025
RNA sequencing (RNA-Seq) is a powerful tool that can be applied at various stages of the drug discovery and development
Categories
Lexogen GmbH
Campus Vienna Biocenter 5
1030 Vienna, Austria
Telephone:
+43 (0) 1 345 1212
Sales support:
+43 (0) 1 345 1212-42
Technical support:
+43 (0) 1 345 1212-41
Working hours: 9:00 – 17:00 (CET)
Fax: +43 (0) 1 345 1212-99
Email: info@lexogen.com
Company number: FN 297318 h
VAT number: ATU63622048
Lexogen, Inc.
51 Autumn Pond Park
Greenland, NH 03840, US
Telephone:
+1-603-431-4300 ext.0
+1-877-Lexogen
(+1-877-539-6436) ext. 0
Sales inquiries:
Northeast: +1-312-978-6413
Southeast: +1-615-968-3325
Northwest: +1-415-726-4318
Southwest: +1-520-934-0678
Technical support:
+1-949-767-1631
(Working hours: 9:00 – 17:00 (EST))
+1-603-498-1666
(Working hours: 7:30 – 15:30 (CST))
Fax: +1-603-431-4333
Lexogen Newsletter
Subscribe to our mailing list to be among the first to get updates from us!
Copyright © 2026 Lexogen GmbH. All rights reserved | Impressum | Privacy Policy | Terms and Conditions | Whistleblowing
Cart
Product
Product Short Description
PRICE
Product
Product Short Description
PRICE
Product
Product Short Description
PRICE